NOVO.B.DK

349.1

+0.82%↑

GMAB.DK

1,800

-1.42%↓

HLUNB.DK

42.72

-0.23%↓

ZEAL.DK

410.3

-4.4%↓

AMBUB.DK

96.6

+0.47%↑

NOVO.B.DK

349.1

+0.82%↑

GMAB.DK

1,800

-1.42%↓

HLUNB.DK

42.72

-0.23%↓

ZEAL.DK

410.3

-4.4%↓

AMBUB.DK

96.6

+0.47%↑

NOVO.B.DK

349.1

+0.82%↑

GMAB.DK

1,800

-1.42%↓

HLUNB.DK

42.72

-0.23%↓

ZEAL.DK

410.3

-4.4%↓

AMBUB.DK

96.6

+0.47%↑

NOVO.B.DK

349.1

+0.82%↑

GMAB.DK

1,800

-1.42%↓

HLUNB.DK

42.72

-0.23%↓

ZEAL.DK

410.3

-4.4%↓

AMBUB.DK

96.6

+0.47%↑

NOVO.B.DK

349.1

+0.82%↑

GMAB.DK

1,800

-1.42%↓

HLUNB.DK

42.72

-0.23%↓

ZEAL.DK

410.3

-4.4%↓

AMBUB.DK

96.6

+0.47%↑

Search

Coloplast A-S (Class B)

Uždarymo kaina

616.4 -0.23

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

615.8

Max

618.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-107M

805M

Pardavimai

28M

7B

P/E

Sektoriaus vid.

34.859

35.664

Pelnas, tenkantis vienai akcijai

4.93

Dividendų pajamingumas

3.54

Pelno marža

11.569

Darbuotojai

16,814

EBITDA

2.2B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.86% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.54%

3.12%

Kitas uždarbis

2025-11-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

5.3B

142B

Ankstesnė atidarymo kaina

616.63

Ankstesnė uždarymo kaina

616.4

Coloplast A-S (Class B) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-12 22:41; UTC

Pagrindinės rinkos jėgos

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

2025-09-12 16:04; UTC

Pagrindinės rinkos jėgos

Upexi Shares Climb on Solana Gains

2025-09-12 15:03; UTC

Pagrindinės rinkos jėgos

Allied Gaming & Entertainment Shares Surge Following Crypto Investments

2025-09-12 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-09-12 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 20:09; UTC

Uždarbis

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

2025-09-12 19:23; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:16; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:03; UTC

Rinkos pokalbiai

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

2025-09-12 18:59; UTC

Rinkos pokalbiai

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

2025-09-12 18:38; UTC

Rinkos pokalbiai
Uždarbis

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

2025-09-12 18:33; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

2025-09-12 18:22; UTC

Rinkos pokalbiai

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

2025-09-12 16:56; UTC

Rinkos pokalbiai

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

2025-09-12 16:22; UTC

Uždarbis

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

2025-09-12 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 16:19; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

2025-09-12 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-09-12 16:11; UTC

Uždarbis

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

2025-09-12 15:37; UTC

Rinkos pokalbiai

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

2025-09-12 15:22; UTC

Rinkos pokalbiai

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

2025-09-12 15:07; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

2025-09-12 14:34; UTC

Rinkos pokalbiai

Russia Sanctions Put Bid Back in Oil -- Market Talk

2025-09-12 14:10; UTC

Rinkos pokalbiai

Inflation Report Unlikely to Dissuade Canada From Rate Cut -- Market Talk

2025-09-12 13:58; UTC

Rinkos pokalbiai

Dollar Could Rise if Fed Sounds Cautious on Rate Cuts -- Market Talk

2025-09-12 13:58; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Super Micro, Adobe, Microsoft, Figure Technology, and More -- Barrons.com

2025-09-12 13:57; UTC

Uždarbis

AbbVie Stock Hit a Record on 'Big Win' for Blockbuster Drug. The Case for Buying In. -- Barrons.com

2025-09-12 13:56; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-12 13:56; UTC

Rinkos pokalbiai

Canadian Dollar Faces Further Weakness Vs Non-U.S. Dollar Currencies -- Market Talk

2025-09-12 13:54; UTC

Rinkos pokalbiai

U.S. Natural Gas Recovers Ground -- Market Talk

Akcijų palyginimas

Kainos pokytis

Coloplast A-S (Class B) Prognozė

Kainos tikslas

By TipRanks

11.86% į viršų

12 mėnesių prognozė

Vidutinis 901.38 DKK  11.86%

Aukščiausias 1,056 DKK

Žemiausias 720 DKK

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Coloplast A-S (Class B) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

4

Laikyti

2

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat